x 

0 Activities
0 Activities
    • No Saved Activities
Page 2 of 2
Results 76 - 129 of 129
No image set
Minimizing Neurodegenerative Damage in Patients with MS
No image set
Recognizing Progressive Disease: A Challenge in the MS Clinic
No image set
MDA Conference Coverage
No image set
Engaging Patients with MS and the Care Team in Shared Decision-Making
No image set
Advances in MS Assessment: Biomarkers and Imaging
No image set
Defining the Clinical Course of Multiple Sclerosis
No image set
Engaging the Patient in Treatment Choices
No image set
DMT Treatment Review
No image set
WMS Conference Coverage on DMD and LGMD: Experts Reporting From the Field
No image set
Updates in SMA: WMS Conference Coverage (CME/CE)
No image set
Updates in SMA: WMS Conference Coverage
No image set
SMA: Introduction and Key Concepts
No image set
Conference Coverage on DMD & LGMD
No image set
Controversies in Progressive MS: Managing Progressive Disease
No image set
Controversies in Progressive MS: Transition to Progressive Disease
No image set
Controversies in Progressive MS: Focus on Diagnosis
No image set
Hereditary Transthyretin Amyloidosis: Case Studies
No image set
hATTR Amyloidosis: You and Your Family
No image set
The SLE Consult: Diagnosis, Treatment Selection, Treatment Targets, and Monitoring
No image set
The SLE Consult: Lupus Nephritis, Patient-Clinician Communication, and Treatment Adherence
No image set
Advances in Multiple Sclerosis (AIMS) Primer: 3rd Edition
No image set
A Practical Guide to Rehabilitation in Multiple Sclerosis: 2nd Edition
No image set
SMA Updates from Around the World
9920-0004-conf_covg_icon_263x149
Updates in SMA from Charlotte, North Carolina
castro-tff
Updates in SMA from Austin, Texas
No image set
Technology Improving SMA Patients’ Quality of Life
No image set
Nusinersen Treatment Outcomes in Later-Onset SMA
No image set
Patients with Severe SMA Need Additional Respiratory Management
Castro_02
Clear Expectations Needed in SMA Patient Management
Castro_01
Improvements in Quality of Life for Patients with Neuromuscular Diseases
9927-264x150
Updates in SMA and Gene Therapy from Copenhagen, Denmark
9920-264x150
The Changing Landscape of SMA–Updates from Copenhagen, Denmark
sma-icon
Are You Ready for Gene Replacement Therapy?
curesma19-icon
The Changing Landscape of SMA–Updates from Anaheim, CA
9833-0001-icon
Urgency for Early Diagnosis and Treatment of SMA
sma-journal-icon_263x0
Gene Therapy for SMA: An Emerging Treatment Option for a Devastating Disease
9834-0002
SMA: Data, Insights and Practice
9829-0001
From Bench to Bedside: Gene Therapy Approaches for Rare Diseases
9808-0004
What’s New in Spinal Muscular Atrophy? Reporting from Dallas
9808-0003
SMA Updates from Los Angeles
9808-0002
Updates in SMA and Gene Therapy from Arlington, VA
aims icon-target
Targeting B-cells in Primary Progressive MS (PPMS)
aims icon-comorb
Comorbidities and Selection of DMTs
aims icon-gut
The Gut Microbiota in MS
aims icon-early
Early MS: Induction Therapy and Escalation Strategies
aims icon-vitamin
Vitamin D: Modifiable Risk Factor and its Role in the Management of Patients with MS
No image set
Individualizing Patient Education in Treatment Choice: Practical Strategies
lgmw-05
A 30 y/o Female w/2-year History of Shoulder Weakness and Elevated AST and ALT
lgmw-04
32 y/o Male w/Progressive Weakness, Dilated Cardiomyopathy & Respiratory...
lgmw-03
A 60 y/o Male w/4-year History Of Shoulder Weakness
No image set
Individualizing Patient Education in Treatment Choice: Practical Strategies
No image set
Addressing Common Barriers to Adherence
9529-00028
Approach to Genetic Testing in Myopathies
9529-00014
Molecular Diagnosis of Limb-Girdle Muscle Weakness
Page 2 of 2

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

10 Vista Drive, Old Lyme, CT USA

Search